Zobrazeno 1 - 10
of 31
pro vyhledávání: '"L G Babicheva"'
Autor:
L. G. Babicheva
Publikováno v:
Онкогематология, Vol 17, Iss 4, Pp 138-157 (2022)
Externí odkaz:
https://doaj.org/article/036ef7ab9dca4986b6ea2e8f3a137435
Prevention of neutropenia as an important factor in successful chemotherapy for head and neck cancer
Autor:
L. G. Babicheva, S. O. Podvyaznikov
Publikováno v:
Опухоли головы и шеи, Vol 11, Iss 3, Pp 72-82 (2021)
Despite the advances in supportive care for cancer patients, they often develop such a serious complication of chemotherapy as febrile neutropenia. This disorder is the main cause of reduced treatment efficacy because of the lower doses of cytostatic
Externí odkaz:
https://doaj.org/article/06bbeac311de45fba6fd18368639847b
Autor:
I. V. Poddubnaya, G. S. Tumian, O. P. Trofimova, L. G. Babicheva, E. A. Bariakh, A. S. Poliakov
Publikováno v:
Современная онкология, Vol 22, Iss 3, Pp 45-58 (2020)
Features of management of oncohematological patients in the context of the COVID-19 pandemic. Lecture
Externí odkaz:
https://doaj.org/article/d56ba0dc980e477abd2f7695083e3e56
Autor:
L. G. Babicheva, I. V. Poddubnaya
Publikováno v:
Онкогематология, Vol 15, Iss 2, Pp 10-18 (2020)
The objective: evaluation of effectiveness of the first-line therapy with rituximab of B-cell lymphoproliferative diseases in Russian clinical practice in the period from 2014 to 2017.Materials and methods. The EQUILIBRIUM post-registration multicent
Externí odkaz:
https://doaj.org/article/fe4126e9487245c9889871b7b499893e
Autor:
I. V. Poddubnaya, D. A. Sychev, G. R. Abuzarova, A. K. Allakhverdiev, P. P. Arkhiri, L. G. Babicheva, M. P. Baranova, M. I. Volkova, A. V. Ignatova, A. Iu. Kashurnikov, R. I. Kniazev, I. V. Kolyadina, I. G. Komarov, A. V. Kriukov, N. V. Levitskaia, V. K. Liadov, O. A. Malikhova, S. N. Nered, N. F. Orel, S. O. Podviaznikov, I. V. Sagaidak, R. R. Sarmanaeva, I. S. Stilidi, O. P. Trofimova, G. S. Tumian, T. V. Kharitonova
Publikováno v:
Современная онкология, Vol 22, Iss 2, Pp 56-73 (2020)
The training module was developed by the staff of the department under the leadership of the head. Department of Academician of RAS, Professor I.V. Poddubnoy and Rector of FSBEI DPO RMANPO of the Ministry of Health of Russia, Corr. RAS, Professor D.A
Externí odkaz:
https://doaj.org/article/828b754feb9b44bfa87fb7395a012d1c
Autor:
L G Babicheva, I V Poddubnaya
Publikováno v:
Современная онкология, Vol 20, Iss 4, Pp 41-46 (2018)
Bendamustine is a uniquely structuredalkylating agent that lacks cross-resistance with other alkylators. This agent has a high degreeof activity against a variety of tumor cell lines.Based on clinical data from randomized phase III trials, bendamusti
Externí odkaz:
https://doaj.org/article/4b634ec4c6b3404792fc3847758e7455
Autor:
L G Babicheva, V V Baikov, E E Leenman, Yu N Vinogradova, N V Ilyin, V V Ryabchikova, I V Poddubnaya
Publikováno v:
Современная онкология, Vol 18, Iss 2, Pp 19-26 (2016)
Primary presentation of intradural non-Hodgkin lymphoma (PDL) is rare. Most published cases of PDL are single-patient reports. This lesion occurs more often in middle-aged women, in contrast to brain parenchyma primary central nervous system lymphoma
Externí odkaz:
https://doaj.org/article/402df309e5e14c5d91726b6b7dadc38c
Prevention of neutropenia as an important factor in successful chemotherapy for head and neck cancer
Autor:
S. O. Podvyaznikov, L. G. Babicheva
Publikováno v:
Opuholi Golovy i Šei, Vol 11, Iss 3, Pp 72-82 (2021)
Despite the advances in supportive care for cancer patients, they often develop such a serious complication of chemotherapy as febrile neutropenia. This disorder is the main cause of reduced treatment efficacy because of the lower doses of cytostatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f32891afa58a8d5bbb16494ceb3fdb7f
https://doi.org/10.17650/2222-1468-2021-11-3-72-82
https://doi.org/10.17650/2222-1468-2021-11-3-72-82
Autor:
L G Babicheva
Publikováno v:
Современная онкология, Vol 17, Iss 5, Pp 7-21 (2015)
Primary non-Hodgkin’s lymphoma of the CNS, testis, pancreatic is a rare entity. Etiology and pathogenesis of these NHLs are unknown, although there might be a possible association between chronic inflammation and lymphomas. The most common histolog
Externí odkaz:
https://doaj.org/article/586a40cd8eed4164b8b295962b227f27
Autor:
L G Babicheva
Publikováno v:
Современная онкология, Vol 23, Iss 1, Pp 172-184 (2021)
Relevance. Follicular lymphoma (FL) and marginal zone lymphoma (MZL) are the most common variants of indolent non-Hodgkin lymphoma (iNHL). Despite the adequate choice of the first-line therapy, 10 15% of affected patients with iNHL develop refractory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cad1f01b4ebe59689d68f952f669b3ea
https://modernonco.orscience.ru/1815-1434/article/viewFile/70486/51402
https://modernonco.orscience.ru/1815-1434/article/viewFile/70486/51402